| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:1604845 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PPAP2B mRNA | CTD | PMID:22079256 |
| 17alpha-ethynylestradiol | affects expression | ISO | RGD:731972 | 6480464 | Ethinyl Estradiol affects the expression of PPAP2B mRNA | CTD | PMID:17555576 |
| 17alpha-ethynylestradiol | decreases expression | EXP | | 6480464 | Ethinyl Estradiol results in decreased expression of PPAP2B mRNA | CTD | PMID:17557909 |
| 17beta-estradiol | multiple interactions | ISO | RGD:1604845 | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of PPAP2B mRNA | CTD | PMID:19619570 |
| 17beta-estradiol | increases expression | ISO | RGD:1604845 | 6480464 | Estradiol results in increased expression of PPAP2B mRNA | CTD | PMID:23019147 |
| 17beta-estradiol | decreases expression | ISO | RGD:1604845 | 6480464 | Estradiol results in decreased expression of PPAP2B mRNA | CTD | PMID:19619570 PMID:16474171 |
| 17beta-estradiol | decreases expression | ISO | RGD:1604845 | 6480464 | Estradiol results in decreased expression of PPAP2B mRNA | CTD | PMID:16474171 PMID:19619570 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1604845 | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of PPAP2B mRNA | CTD | PMID:19619570 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:731972 | 6480464 | Tetrachlorodibenzodioxin affects the expression of PPAP2B mRNA | CTD | PMID:16962184 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1604845 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PPAP2B mRNA | CTD | PMID:11007951 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:731972 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PPAP2B mRNA | CTD | PMID:19933214 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:731972 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PPAP2B mRNA | CTD | PMID:18796159 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:731972 | 6480464 | Tetrachlorodibenzodioxin affects the expression of PPAP2B mRNA | CTD | PMID:16962184 PMID:20702594 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1604845 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PPAP2B mRNA | CTD | PMID:19619570 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:731972 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PPAP2B mRNA | CTD | PMID:19770486 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1604845 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PPAP2B mRNA | CTD | PMID:19619570 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:731972 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PPAP2B mRNA | CTD | PMID:18796159 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:731972 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PPAP2B mRNA | CTD | PMID:19933214 PMID:18796159 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PPAP2B mRNA | CTD | PMID:19490992 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:731972 | 6480464 | [Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of PPAP2B mRNA | CTD | PMID:16214954 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:731972 | 6480464 | Tetrachlorodibenzodioxin affects the expression of PPAP2B mRNA | CTD | PMID:20702594 PMID:16962184 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1604845 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PPAP2B mRNA | CTD | PMID:11007951 more ... |
| 2-amino-2-deoxy-D-glucopyranose | decreases expression | EXP | | 6480464 | Glucosamine results in decreased expression of PPAP2B mRNA | CTD | PMID:17109745 |
| 3-methylcholanthrene | decreases expression | ISO | RGD:731972 | 6480464 | Methylcholanthrene results in decreased expression of PPAP2B mRNA | CTD | PMID:20713471 |
| 3H-1,2-dithiole-3-thione | decreases expression | EXP | | 6480464 | 1,2-dithiol-3-thione results in decreased expression of PPAP2B mRNA | CTD | PMID:19162173 |
| 4,4'-diaminodiphenylmethane | decreases expression | ISO | RGD:731972 | 6480464 | 4,4'-diaminodiphenylmethane results in decreased expression of PPAP2B mRNA | CTD | PMID:18648102 |
| 4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid | increases expression | ISO | RGD:1604845 | 6480464 | Am 580 results in increased expression of PPAP2B mRNA | CTD | PMID:16982809 |
| aflatoxin B1 | increases expression | ISO | RGD:731972 | 6480464 | Aflatoxin B1 results in increased expression of PPAP2B mRNA | CTD | PMID:19770486 |
| aldehydo-D-glucosamine | decreases expression | EXP | | 6480464 | Glucosamine results in decreased expression of PPAP2B mRNA | CTD | PMID:17109745 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of PPAP2B mRNA | CTD | PMID:16483693 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1604845 | 6480464 | Benzo(a)pyrene results in decreased expression of PPAP2B mRNA | CTD | PMID:20064835 PMID:20106945 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1604845 | 6480464 | Benzo(a)pyrene results in decreased expression of PPAP2B mRNA | CTD | PMID:20064835 more ... |
| benzo[a]pyrene | decreases expression | ISO | RGD:1604845 | 6480464 | Benzo(a)pyrene results in decreased expression of PPAP2B mRNA | CTD | PMID:20064835 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:731972 | 6480464 | Benzo(a)pyrene results in increased expression of PPAP2B mRNA | CTD | PMID:19770486 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1604845 | 6480464 | Benzo(a)pyrene results in decreased expression of PPAP2B mRNA | CTD | PMID:20106945 PMID:20064835 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:731972 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of PPAP2B mRNA; more ... | CTD | PMID:21715664 |
| beta-D-glucosamine | decreases expression | EXP | | 6480464 | Glucosamine results in decreased expression of PPAP2B mRNA | CTD | PMID:17109745 |
| bisphenol A | decreases expression | ISO | RGD:1604845 | 6480464 | bisphenol A results in decreased expression of PPAP2B mRNA | CTD | PMID:16474171 |
| cadmium sulfate | multiple interactions | ISO | RGD:731972 | 6480464 | cadmium sulfate affects the reaction [MTF1 affects the expression of PPAP2B mRNA] | CTD | PMID:16221973 |
| chloroprene | increases expression | EXP | | 6480464 | Chloroprene results in increased expression of PPAP2B mRNA | CTD | PMID:23125180 |
| choline | multiple interactions | ISO | RGD:731972 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of PPAP2B mRNA | CTD | PMID:20938992 |
| clofibric acid | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of PPAP2B mRNA | CTD | PMID:17602206 |
| cocaine | increases expression | EXP | | 6480464 | Cocaine results in increased expression of PPAP2B mRNA | CTD | PMID:17898221 |
| copper(2+) sulfate | decreases expression | ISO | RGD:1604845 | 6480464 | Copper Sulfate results in decreased expression of PPAP2B mRNA | CTD | PMID:19549813 |
| crocidolite asbestos | increases expression | ISO | RGD:1604845 | 6480464 | Asbestos, Crocidolite results in increased expression of PPAP2B mRNA | CTD | PMID:18687144 |
| cyclosporin A | decreases expression | ISO | RGD:1604845 | 6480464 | Cyclosporine results in decreased expression of PPAP2B mRNA | CTD | PMID:20106945 |
| Delta(9)-tetrahydrocannabinol | increases expression | ISO | RGD:731972 | 6480464 | Tetrahydrocannabinol results in increased expression of PPAP2B mRNA | CTD | PMID:21542829 |
| diarsenic trioxide | increases expression | ISO | RGD:1604845 | 6480464 | arsenic trioxide results in increased expression of PPAP2B mRNA | CTD | PMID:19128835 |
| dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of PPAP2B mRNA | CTD | PMID:21266533 |
| elemental selenium | decreases expression | ISO | RGD:1604845 | 6480464 | Selenium results in decreased expression of PPAP2B mRNA | CTD | PMID:19244175 |
| ethanol | increases expression | ISO | RGD:731972 | 6480464 | Ethanol results in increased expression of PPAP2B mRNA | CTD | PMID:19167417 |
| folic acid | multiple interactions | ISO | RGD:731972 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of PPAP2B mRNA | CTD | PMID:20938992 |
| gamma-hexachlorocyclohexane | increases expression | EXP | | 6480464 | Lindane results in increased expression of PPAP2B mRNA | CTD | PMID:17785943 |
| genistein | decreases expression | ISO | RGD:1604845 | 6480464 | Genistein results in decreased expression of PPAP2B mRNA | CTD | PMID:16474171 |
| genistein | increases expression | ISO | RGD:1604845 | 6480464 | Genistein results in increased expression of PPAP2B mRNA | CTD | PMID:23019147 |
| hydrogen chloride | decreases expression | ISO | RGD:1604845 | 6480464 | Hydrochloric Acid results in decreased expression of PPAP2B mRNA | CTD | PMID:15046208 |
| hydrogen peroxide | affects expression | ISO | RGD:1604845 | 6480464 | Hydrogen Peroxide affects the expression of PPAP2B mRNA | CTD | PMID:20044591 |
| isotretinoin | increases expression | ISO | RGD:1604845 | 6480464 | Isotretinoin results in increased expression of PPAP2B mRNA | CTD | PMID:20436886 |
| L-methionine | multiple interactions | ISO | RGD:731972 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of PPAP2B mRNA | CTD | PMID:20938992 |
| lead diacetate | increases expression | ISO | RGD:731972 | 6480464 | lead acetate results in increased expression of PPAP2B mRNA | CTD | PMID:20542052 |
| methotrexate | increases expression | ISO | RGD:1604845 | 6480464 | Methotrexate results in increased expression of PPAP2B mRNA | CTD | PMID:17400583 |
| N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of PPAP2B mRNA | CTD | PMID:20360939 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of PPAP2B mRNA | CTD | PMID:17602206 |
| nickel dichloride | affects expression | EXP | | 6480464 | nickel chloride affects the expression of PPAP2B mRNA | CTD | PMID:22110744 |
| nickel dichloride | increases expression | ISO | RGD:1604845 | 6480464 | nickel chloride results in increased expression of PPAP2B mRNA | CTD | PMID:17312168 |
| paracetamol | decreases expression | ISO | RGD:731972 | 6480464 | Acetaminophen results in decreased expression of PPAP2B mRNA | CTD | PMID:18544908 |
| paracetamol | decreases expression | ISO | RGD:1604845 | 6480464 | Acetaminophen results in decreased expression of PPAP2B mRNA | CTD | PMID:21420995 |
| paracetamol | affects expression | ISO | RGD:731972 | 6480464 | Acetaminophen affects the expression of PPAP2B mRNA | CTD | PMID:17562736 |
| perfluorooctanoic acid | decreases expression | EXP | | 6480464 | perfluorooctanoic acid results in decreased expression of PPAP2B mRNA | CTD | PMID:19162173 |
| pirinixic acid | decreases expression | EXP | | 6480464 | pirinixic acid results in decreased expression of PPAP2B mRNA | CTD | PMID:19162173 |
| pirinixic acid | multiple interactions | ISO | RGD:731972 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PPAP2B mRNA | CTD | PMID:19710929 |
| pregnenolone 16alpha-carbonitrile | decreases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in decreased expression of PPAP2B mRNA | CTD | PMID:19162173 |
| propiconazole | decreases expression | ISO | RGD:731972 | 6480464 | propiconazole results in decreased expression of PPAP2B mRNA | CTD | PMID:21278054 |
| propiconazole | decreases expression | EXP | | 6480464 | propiconazole results in decreased expression of PPAP2B mRNA | CTD | PMID:19423681 |
| raloxifene | multiple interactions | ISO | RGD:1604845 | 6480464 | ESR1 protein affects the reaction [Raloxifene results in increased expression of PPAP2B mRNA] | CTD | PMID:14699072 |
| raloxifene | affects expression | ISO | RGD:1604845 | 6480464 | Raloxifene affects the expression of PPAP2B mRNA | CTD | PMID:14699072 |
| rosiglitazone | increases expression | ISO | RGD:1604845 | 6480464 | rosiglitazone results in increased expression of PPAP2B mRNA | CTD | PMID:16982809 |
| rosiglitazone | decreases expression | ISO | RGD:731972 | 6480464 | rosiglitazone results in decreased expression of PPAP2B mRNA | CTD | PMID:17245590 |
| selenium atom | decreases expression | ISO | RGD:1604845 | 6480464 | Selenium results in decreased expression of PPAP2B mRNA | CTD | PMID:19244175 |
| sodium dichromate | affects expression | EXP | | 6480464 | sodium bichromate affects the expression of PPAP2B mRNA | CTD | PMID:22110744 |
| succimer | multiple interactions | ISO | RGD:731972 | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in increased expression of PPAP2B mRNA | CTD | PMID:21641980 |
| tamoxifen | affects expression | ISO | RGD:731972 | 6480464 | Tamoxifen affects the expression of PPAP2B mRNA | CTD | PMID:17555576 |
| testosterone enanthate | affects expression | ISO | RGD:1604845 | 6480464 | testosterone enanthate affects the expression of PPAP2B mRNA | CTD | PMID:17440010 |
| tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of PPAP2B mRNA | CTD | PMID:16239168 |
| zinc atom | multiple interactions | ISO | RGD:1604845 | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of PPAP2B mRNA | CTD | PMID:18593933 |
| zinc(0) | multiple interactions | ISO | RGD:1604845 | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of PPAP2B mRNA | CTD | PMID:18593933 |